NCT07762144

Brief Summary

Cardiac arrest is one of the leading life-threatening emergencies, with approximately 540,000 cases occurring annually in China. Among patients who experience cardiac arrest, active cardiopulmonary resuscitation can achieve return of spontaneous circulation in 40% of cases; however, only 1-2% ultimately survive with favorable neurological outcomes. The primary contributor to mortality and morbidity is post-cardiac arrest syndrome (PCAS). PCAS represents a distinct pathophysiological process resulting from systemic ischemia/reperfusion injury, involving multiple systems and organs, and thus requires comprehensive, systematic evaluation. At present, numerous challenges remain in the field of PCAS, including the optimal targeted temperature, additional interventions that may improve neurological prognosis, post-resuscitation myocardial dysfunction and its protective strategies, characteristics and management of dysfunction in other organs, and accurate neurological prognostication after resuscitation. Therefore, in-depth research on PCAS is urgently needed to improve outcomes in cardiac arrest survivors. This study is initiated by the Department of Emergency Medicine, Peking University Third Hospital, and involves a total of six tertiary hospitals across China, constituting a multicenter investigation. The study aims to explore the effects of different targeted temperature management strategies on mortality and neurological outcomes, and to actively investigate other interventions that may ameliorate post-resuscitation brain injury, cardiac injury, and microcirculatory dysfunction, thereby reducing mortality and improving neurological prognosis in cardiac arrest patients. Furthermore, we aim to develop a neurological prediction model for cardiac arrest patients to enable accurate prognostication of neurological outcomes, which will assist emergency physicians in providing precise prognostic information to families and facilitate shared decision-making regarding subsequent treatment plans.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
53mo left

Started Jan 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Jan 2014Dec 2030

Study Start

First participant enrolled

January 1, 2014

Completed
12.5 years until next milestone

First Submitted

Initial submission to the registry

June 24, 2026

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 13, 2026

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2030

Last Updated

August 13, 2026

Status Verified

August 1, 2026

Enrollment Period

17 years

First QC Date

June 24, 2026

Last Update Submit

August 11, 2026

Conditions

Keywords

Cardiac Arrest

Outcome Measures

Primary Outcomes (1)

  • Whether death has occurred

    Death: any death, regardless of cause (i.e., all-cause mortality)

    1 year

Secondary Outcomes (1)

  • Assessment of neurological prognosis

    1year

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study will enroll all eligible patients presenting to the emergency departments of the six centers who satisfy the following inclusion and exclusion criteria

You may qualify if:

  • Patients who have achieved return of spontaneous circulation (ROSC) after cardiac arrest;
  • With accessible intravenous or intraosseous vascular access;
  • Clinical manifestations meeting any one of the following criteria: presenting with post-resuscitation brain injury, post-resuscitation cardiac dysfunction, manifestations of systemic ischemia-reperfusion injury, or other ongoing deteriorating pathological changes.

You may not qualify if:

  • Patients who have not achieved return of spontaneous circulation (ROSC) after cardiac arrest;
  • Patients who have declined cardiopulmonary resuscitation (CPR) (or whose legally authorized representative has refused CPR).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emergency Dept of Peking University Third Hospital

Beijing, Beijing Municipality, 100191, China

Location

Related Publications (5)

  • Belbasis L, Bellou V. Introduction to Epidemiological Studies. Methods Mol Biol. 2018;1793:1-6. doi: 10.1007/978-1-4939-7868-7_1.

    PMID: 29876887BACKGROUND
  • Jentzer JC, Chonde MD, Dezfulian C. Myocardial Dysfunction and Shock after Cardiac Arrest. Biomed Res Int. 2015;2015:314796. doi: 10.1155/2015/314796. Epub 2015 Sep 2.

    PMID: 26421284BACKGROUND
  • Lundin A, Djarv T, Engdahl J, Hollenberg J, Nordberg P, Ravn-Fischer A, Ringh M, Rysz S, Svensson L, Herlitz J, Lundgren P. Drug therapy in cardiac arrest: a review of the literature. Eur Heart J Cardiovasc Pharmacother. 2016 Jan;2(1):54-75. doi: 10.1093/ehjcvp/pvv047. Epub 2015 Nov 26.

    PMID: 27533062BACKGROUND
  • Shao F, Li CS, Liang LR, Qin J, Ding N, Fu Y, Yang K, Zhang GQ, Zhao L, Zhao B, Zhu ZZ, Yang LP, Yu DM, Song ZJ, Yang QL. Incidence and outcome of adult in-hospital cardiac arrest in Beijing, China. Resuscitation. 2016 May;102:51-6. doi: 10.1016/j.resuscitation.2016.02.002. Epub 2016 Feb 23.

    PMID: 26924514BACKGROUND
  • Trzeciak S, Jones AE, Kilgannon JH, Milcarek B, Hunter K, Shapiro NI, Hollenberg SM, Dellinger P, Parrillo JE. Significance of arterial hypotension after resuscitation from cardiac arrest. Crit Care Med. 2009 Nov;37(11):2895-903; quiz 2904. doi: 10.1097/ccm.0b013e3181b01d8c.

    PMID: 19866506BACKGROUND

MeSH Terms

Conditions

Post-Cardiac Arrest SyndromeHeart Arrest

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesHeart DiseasesCardiovascular DiseasesReperfusion InjuryVascular DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Qing bian Ma, Doctor of Medicine

    Peking University Third Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of the Emergency Department, Peking University Third Hospital

Study Record Dates

First Submitted

June 24, 2026

First Posted

August 13, 2026

Study Start

January 1, 2014

Primary Completion (Estimated)

December 31, 2030

Study Completion (Estimated)

December 31, 2030

Last Updated

August 13, 2026

Record last verified: 2026-08

Locations